Breaking News Instant updates and real-time market news.

LULU

lululemon

$60.13

0.79 (1.33%)

, NKE

Nike

$52.67

-1.03 (-1.92%)

08:48
09/28/17
09/28
08:48
09/28/17
08:48

lululemon CEO says retail alive as people 'crave human connections', CNBC says

Lululemon (LULU) CEO Laurent Potdevin said he does not believe brick-and-mortar retail will fade as "people continue to crave human connections," CNBC reports, citing an interview. Potdevin noted the weakness in other athletic retailer such as Nike (NKE) but said lululemon is different as it does not deal in footwear and it has roughly 2,500 brand ambassadors across communities to foster human engagement and assist the company in keeping its "finger on the pulse." Reference Link

LULU

lululemon

$60.13

0.79 (1.33%)

NKE

Nike

$52.67

-1.03 (-1.92%)

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

LULU lululemon
$60.13

0.79 (1.33%)

09/05/17
09/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Outperform from Market Perform at Wells Fargo with analyst Marci Ryvicker saying concerns over potential dilution from the BAMTech stake and the streaming apps are "widely overdone." 2. Patterson-UTI (PTEN) upgraded to Overweight from Neutral at JPMorgan with analyst Sean Meakim saying the 26% selloff since July 19 has created a buying opportunity. 3. lululemon (LULU) upgraded to Positive from Neutral at Susquehanna with analyst Sam Poser citing improved product mix, momentum carrying into the third quarter and inventory flow to stores that is finally supporting consumer engagement. 4. U.S. Steel (X) upgraded to Buy from Neutral at BofA/Merrill with analyst Timna Tanners saying the U.S. premium to Chinese prices has fallen to just about $75/ton, half the leves he considers "normal" and expects HRC can "surge toward $700/ton by year end. 5. Prologis (PLD) upgraded to Buy from Hold at SunTrust with analyst Ki Bin Kim citing valuation and several positive catalysts. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/12/17
BERN
09/12/17
INITIATION
Target $66
BERN
Market Perform
lululemon initiated with a Market Perform at Bernstein
Bernstein analyst Jamie Merriman started lululemon with a Market Perform rating and $66 price target.
09/19/17
WELS
09/19/17
DOWNGRADE
Target $13
WELS
Underperform
Under Armour downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo analyst Tom Nikic downgraded Under Armour (UAA) to Underperform and cut his price target for the shares to $13 from $17. With consumers having filled their closets with athletic wear over the past seven years, the category "appears poised to take a breather for now," Nikic tells investors in a research note. The analyst believes the trend change away from performance has left Under Armour "offsides" from a fashion perspective. Further, he notes that unlike Nike (NKE), Under Armour still generates most of its revenue in North America, where the athletic space is seeing much more pressure. The stock's valuation "still appears quite lofty," Nikic argues. The analyst lowered his estimates for Nike, Under Armour, lululemon (LULU) and Finish Line (FINL), but downgraded only Under Armour.
09/26/17
BERN
09/26/17
NO CHANGE
BERN
Survey respondents more likely to buy Nike for fashion/function, says Bernstein
Bernstein analyst Jamie Merriman says he and his firm surveyed 1000 people in the U.S. in July, asking them about 22 athletic apparel and footwear brands. At the athletic apparel and footwear category level, 58% of survey respondents expect to spend about the same amount on the category as they have spent over the last 12 months, while 28% expect to spend more and 14% expect to spend less, he notes. Among those who had shopped the brands in the LTM, the analyst says theintention to purchase more in the NTM was similar across Nike (NKE), adidas (ADDYY) and Under Armour (UAA), while Lululemon (LULU) customers reported the highest intention to purchase more going forward. Additionally, Merriman said respondents were most likely to purchase Nike, relative to other brands, for a combination of fashion and function.
NKE Nike
$52.67

-1.03 (-1.92%)

09/27/17
PIPR
09/27/17
NO CHANGE
Target $50
PIPR
Overweight
Piper 'unimpressed' by Nike's quarter, trims price target to $50
Piper Jaffray analyst Erinn Murphy trimmed her price target for Nike shares to $50 from $53 following the company's Q1 results. The analyst says she's "unimpressed" that demand creation, down 18% in Q1, was what "made" the number against an in line sales and lower than expected gross margin result. She adds that the inventory versus sales spread widened quarter-over-quarter by over 700 basis points. Management on the call also set Q2 expectations well below the Street, a familiar trend of late, Murphy writes in a post-earnings research note partially titled "Q1 Results Don't Provide Much Confidence In The Medium Term." The analyst reiterates a Neutral rating on Nike.
09/27/17
JEFF
09/27/17
NO CHANGE
Target $48
JEFF
Hold
Jefferies still not a buyer of Nike after Q1 beat
Jefferies analyst Randal Konik attributes Nike's beat in Q1 to low expectations, cost cuts and share repurchases. Inventories are elevated, gross margin declined and North America sales were down as market share is being lost, Konik tells investors in a post-earnings research note titled "Not A Buyer On Cost Cut Beat. Share Losses, Wholesale Exposure Remain Problems." The analyst trimmed his price target on the shares to $48 from $49 and says he's not a buyer post the results. Konik has a Hold rating on the name.
09/27/17
BOFA
09/27/17
NO CHANGE
Target $42
BOFA
Underperform
Nike risk/reward still unfavorable, says BofA/Merrill
Following Nike's Q1 report and lowered guidance, BofA/Merrill analyst Robert Ohmes expects management to lower its previous $50B revenue target for FY20 closer to his forecast of $40B at its October 25 Investor Day. The analyst continues to view Nike's risk/reward as unfavorable and reiterated his Underperform rating given the challenging North American promotional environment, an extended period of revenue decline and further downward estimates revisions, elevated inventory levels globally, and a growth outlook that relies on improving China momentum and a reacceleration in direct-to-consumer engagement.
09/27/17
MSCO
09/27/17
NO CHANGE
Target $62
MSCO
Overweight
Nike pullback after earnings a 'buy low' opportunity, says Morgan Stanley
Morgan Stanley analyst Jay Sole said he is more bullish on Nike (NKE) after the company revealed with its Q1 report that its new Air VaporMax took top U.S. market share in the high-end price category, implying it outsold Adidas' (ADDYY) "vaunted" Ultra Boost. He also noted that Nike plans to re-implement its MAP pricing policy and is pulling back from unhealthy distribution channels, which he views as "courageous and arguably unexpected steps" that give some explanation for its weak North American guidance. The analyst, who lowered his FY18 EPS estimate by 4% and cut his price target to $62 from $64, keeps an Overweight rating on Nike and contends the post-earnings weakness is an excellent chance to "buy low."

TODAY'S FREE FLY STORIES

JELD

Jeld-Wen

$34.50

-3.14 (-8.34%)

03:27
02/22/18
02/22
03:27
02/22/18
03:27
Downgrade
Jeld-Wen rating change  »

Jeld-Wen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Mar

ALKS

Alkermes

$63.19

-1.56 (-2.41%)

03:27
02/22/18
02/22
03:27
02/22/18
03:27
Downgrade
Alkermes rating change  »

Alkermes downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSA

MSA Safety

$80.25

3.79 (4.96%)

03:25
02/22/18
02/22
03:25
02/22/18
03:25
Upgrade
MSA Safety rating change  »

MSA Safety upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

02:50
02/22/18
02/22
02:50
02/22/18
02:50
General news
FX Update: The dollar has continued to mostly trade firmer »

FX Update: The dollar…

02:15
02/22/18
02/22
02:15
02/22/18
02:15
General news
Asian Market Summary: »

Asian Market Summary:…

00:00
02/22/18
02/22
00:00
02/22/18
00:00
General news
Breaking General news story  »

Federal Reserve Vice…

NEM

Newmont Mining

$38.16

-0.23 (-0.60%)

, HRL

Hormel Foods

$32.68

-1.12 (-3.31%)

20:25
02/21/18
02/21
20:25
02/21/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

NEM

Newmont Mining

$38.16

-0.23 (-0.60%)

HRL

Hormel Foods

$32.68

-1.12 (-3.31%)

APA

Apache

$37.20

-1.1 (-2.87%)

LDOS

Leidos

$65.21

-1.02 (-1.54%)

W

Wayfair

$95.69

-0.61 (-0.63%)

OA

Orbital ATK

$131.80

-0.02 (-0.02%)

TREE

LendingTree

$371.25

-7.8 (-2.06%)

SFM

Sprouts Farmers Market

$26.12

0.12 (0.46%)

TPX

Tempur Sealy

$54.97

1.17 (2.17%)

SAFM

Sanderson Farms

$128.00

-3.44 (-2.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

  • 28

    Feb

  • 07

    Mar

  • 08

    Mar

  • 20

    Mar

  • 29

    Mar

AIMT

Aimmune

$32.21

-2.75 (-7.87%)

20:04
02/21/18
02/21
20:04
02/21/18
20:04
Syndicate
Aimmune 5.5M share Secondary priced at $32.00 »

BofA/Merrill, Cantor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 11

    Mar

  • 22

    Feb

20:00
02/21/18
02/21
20:00
02/21/18
20:00
General news
Breaking General news story  »

Minneapolis Federal…

NUAN

Nuance

$16.28

-0.28 (-1.69%)

19:10
02/21/18
02/21
19:10
02/21/18
19:10
Periodicals
Nuance discontinues Swype feature development, Verge reports »

Nuance has ceased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

SSNLF

Samsung

, QCOM

Qualcomm

$63.40

-0.59 (-0.92%)

19:04
02/21/18
02/21
19:04
02/21/18
19:04
Hot Stocks
Samsung, Qualcomm expand foundry cooperation on EUV process technology »

Samsung Electronics…

SSNLF

Samsung

QCOM

Qualcomm

$63.40

-0.59 (-0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 06

    Mar

CATY

Cathay General

$42.84

0.43 (1.01%)

18:59
02/21/18
02/21
18:59
02/21/18
18:59
Hot Stocks
Cathay General executive chairman Cheng sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUN

Sunoco

$30.00

-0.08 (-0.27%)

18:42
02/21/18
02/21
18:42
02/21/18
18:42
Earnings
Sunoco reports Q4 EPS $2.01, may not compare to consensus 35c »

Reports Q4 revenue $3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

USFD

US Foods

$32.29

0.33 (1.03%)

18:39
02/21/18
02/21
18:39
02/21/18
18:39
Hot Stocks
US Foods director Lederer sells 98,702 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLRS

Volaris

$9.14

0.12 (1.33%)

18:38
02/21/18
02/21
18:38
02/21/18
18:38
Earnings
Volaris reports Q4 28c, consensus 20c »

Reports Q4 revenue $336M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLRS

Volaris

$9.14

0.12 (1.33%)

18:34
02/21/18
02/21
18:34
02/21/18
18:34
Earnings
Breaking Earnings news story on Volaris »

Volaris reports Q4 net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMI

Valmont

$156.55

-0.55 (-0.35%)

18:29
02/21/18
02/21
18:29
02/21/18
18:29
Earnings
Valmont sees 2018 adjusted $8.00, consensus $8.15 »

Sees 2018 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 06

    Mar

VMI

Valmont

$156.55

-0.55 (-0.35%)

18:27
02/21/18
02/21
18:27
02/21/18
18:27
Earnings
Valmont reports Q4 adjusted EPS $1.67, consensus $1.69 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 06

    Mar

CTRV

ContraVir Pharmaceuticals

$0.25

-0.013 (-5.00%)

18:11
02/21/18
02/21
18:11
02/21/18
18:11
Hot Stocks
ContraVir Pharmaceuticals' hepatitis B treatment receives FDA Orphan designation »

ContraVir…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

AAC

AAC Holdings

$8.38

0.25 (3.08%)

18:06
02/21/18
02/21
18:06
02/21/18
18:06
Earnings
AAC Holdings sees FY18 adjusted EPS 70c-75c, consensus 53c »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

AAC

AAC Holdings

$8.38

0.25 (3.08%)

18:05
02/21/18
02/21
18:05
02/21/18
18:05
Earnings
AAC Holdings reports Q4 adjusted EPS 10c, consensus 4c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

DNKN

Dunkin' Brands

$60.70

-1.45 (-2.33%)

18:04
02/21/18
02/21
18:04
02/21/18
18:04
Hot Stocks
Baskin-Robbins expands in Toronto with plans for four new locations »

Baskin-Robbins, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$102.43

0.05 (0.05%)

18:01
02/21/18
02/21
18:01
02/21/18
18:01
Hot Stocks
Celanese to increase price of acetyl intermediate products »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 30

    May

TUSK

Mammoth Energy

$20.04

-0.11 (-0.55%)

17:56
02/21/18
02/21
17:56
02/21/18
17:56
Earnings
Mammoth Energy reports Q4 EPS $1.48, consensus 53c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

NSPR

InspireMD

$4.20

-0.26 (-5.83%)

17:53
02/21/18
02/21
17:53
02/21/18
17:53
Syndicate
Breaking Syndicate news story on InspireMD »

InspireMD files $30M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.